Combined therapy with proton pump inhibitors and clopidogrel – focus on cardiovascular risk

Combined therapy with proton pump inhibitors and clopidogrel – focus on cardiovascular risk

Aim. To analyze accessible studies on the problem of potential interaction of proton pump inhibitors and clopidogrel and to evaluate the influence of combined therapy with these pharmacologic agents on cardiovascular adverse effects development. Materials and methods. Data from 43 foreign and Russi...

Full description

Bibliographic Details
Main Authors: Aleksei I. Kochetkov, Olga D. Ostroumova, Evgenii V. Kravchenko, Olga V. Bondarets, Tatiana F. Guseva
Format: Article
Language:Russian
Published: ZAO "Consilium Medicum" 2019-01-01
Series:Consilium Medicum
Subjects:
clopidogrel
proton memory inhibitors
major adverse cardiovascular events
cardiovascular risk
evidence-based medicine
Online Access:http://consilium.orscience.ru/en/archive/2019/vol-21-1-2019/combined-therapy-with-proton-pump-inhibitors-and-clopidogrel-focus-on-cardiovascular-risk-_5092/?element

Internet

http://consilium.orscience.ru/en/archive/2019/vol-21-1-2019/combined-therapy-with-proton-pump-inhibitors-and-clopidogrel-focus-on-cardiovascular-risk-_5092/?element

Similar Items